Expression and sequence variants of inflammatory genes; Effects on plasma inflammation biomarkers following a 6-week supplementation with fish oil

International Journal of Molecular Sciences

Volumn 17, Issue 3, 2016, Pages

  Cormier, Hubert ^a,b   Rudkowska, Iwona ^c   Lemieux, Simone ^a,b   Couture, Patrick ^a,c   Voh, Marie Claude ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c Université Laval   (Canada)

Author keywords

Inflammation; Nutrigenetics; Omega 3 polyunsaturated fatty acids; Polymorphism

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; C-REACTIVE PROTEIN RECEPTOR, HUMAN; IL6 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; OMEGA 3 FATTY ACID; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD FREQUENCY QUESTIONNAIRE; GENE EXPRESSION; GENETIC ANALYSIS; GENOTYPE; HUMAN; INFLAMMATION; NEPHELOMETRY; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; BLOOD; CHEMISTRY; DIET THERAPY; DIETARY SUPPLEMENT; DRUG EFFECTS; FEMALE; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; GENE EXPRESSION; GENE-ENVIRONMENT INTERACTION; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84961245766     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17030375     Document Type: Article

References (39)

1. Stryjecki, C.; Mutch, D.M. Fatty acid-gene interactions, adipokines and obesity. Eur. J. Clin. Nutr. 2011, 65, 285-297. [CrossRef] [PubMed]
2. Calder, P.C. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 2006, 83,1505S-1519S.
3. Serhan, C.N.; Chiang, N.; Van Dyke, T.E. Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008, 8, 349-361. [CrossRef] [PubMed]
4. Serhan, C.N. Novel omega-3-derived local mediators in anti-inflammation and resolution. Pharmacol. Ther. 2005,105, 7-21. [CrossRef] [PubMed]
5. Tjonahen, E.; Oh, S.F.; Siegelman, J.; Elangovan, S.; Percarpio, K.B.; Hong, S.; Arita, M.; Serhan, C.N. Resolvin E2: Identification and anti-inflammatory actions: Pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. Chem. Biol. 2006,13,1193-1202. [CrossRef] [PubMed]
6. Joffe, Y.T.; Collins, M.; Goedecke, J.H. The relationship between dietary fatty acids and inflammatory genes on the obese phenotype and serum lipids. Nutrients 2013, 5,1672-1705. [CrossRef] [PubMed]
7. Grimble, R.F.; Howell, W.M.; O'Reilly, G.; Turner, S.J.; Markovic, O.; Hirrell, S.; East, J.M.; Calder, P.C. The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor a production. Am. J. Clin. Nutr. 2002, 76, 454-459. [PubMed]
8. Calder, P.C. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol. Nutr. Food Res. 2008, 52, 885-897. [CrossRef] [PubMed]
9. Rudkowska, I.; Paradis, A.M.; Thifault, E.; Julien, P.; Tchernof, A.; Couture, P.; Lemieux, S.; Barbier, O.; Vohl, M.C. Transcriptomic and metabolomic signatures of an n-3 polyunsaturated fatty acids supplementation in a normolipidemic/normocholesterolemic caucasian population. J. Nutr Biochem. 2013,24, 54-61. [CrossRef] [PubMed]
10. Bouwens, M.; van de Rest, O.; Dellschaft, N.; Bromhaar, M.G.; de Groot, L.C.; Geleijnse, J.M.; Muller, M.; Afman, L.A. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am. J. Clin. Nutr. 2009, 90, 415-424. [CrossRef] [PubMed]
11. Thifault, E.; Cormier, H.; Bouchard-Mercier, A.; Rudkowska, I.; Paradis, A.M.; Garneau, V.; Ouellette, C.; Lemieux, S.; Couture, P.; Vohl, M.C. Effects of age, sex, body mass index and APOE genotype on cardiovascular biomarker response to an n-3 polyunsaturated fatty acid supplementation. J. Nutrigenet. Nutrigenom. 2013, 6, 73-82. [CrossRef] [PubMed]
12. Tremblay, B.L.; Rudkowska, I.; Couture, P.; Lemieux, S.; Julien, P.; Vohl, M.C. Modulation of C-reactive protein and plasma omega-6 fatty acid levels by phospholipase A2 gene polymorphisms following a 6-week supplementation with fish oil. Prostaglandins Leukot. Essent. Fat. Acids 2015,102-103,37-45. [CrossRef] [PubMed]
13. Ferrucci, L.; Cherubini, A.; Bandinelli, S.; Bartali, B.; Corsi, A.; Lauretani, F.; Martin, A.; Andres-Lacueva, C.; Senin, U.; Guralnik, J.M. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J. Clin. Endocrinol. Metab. 2006, 91, 439-446. [CrossRef] [PubMed]
14. Trebble, T.; Arden, N.K.; Stroud, M.A.; Wootton, S.A.; Burdge, G.C.; Miles, E.A.; Ballinger, A.B.; Thompson, R.L.; Calder, P.C. Inhibition of tumour necrosis factor-a and interleukin 6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation. Br J. Nutr. 2003, 90, 405-412. [CrossRef] [PubMed]
15. Rees, D.; Miles, E.A.; Banerjee, T.; Wells, S.J.; Roynette, C.E.; Wahle, K.W.; Calder, P.C. Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: A comparison of young and older men. Am. J. Clin. Nutr. 2006, 83, 331-342. [PubMed]
16. Mahajan, A.; Tabassum, R.; Chavali, S.; Dwivedi, O.P.; Chauhan, G.; Tandon, N.; Bharadwaj, D. Obesity-dependent association of TNF-LTA locus with type 2 diabetes in north indians. J. Mol. Med. 2010,88, 515-522. [CrossRef] [PubMed]
17. Teuffel, O.; Ethier, M.C.; Beyene, J.; Sung, L. Association between tumor necrosis factor-a promoter -308 A/G polymorphism and susceptibility to sepsis and sepsis mortality: A systematic review and meta-analysis. Crit. Care Med. 2010, 38, 276-282. [CrossRef] [PubMed]
18. Franke, A.; McGovern, D.P.; Barrett, J.C.; Wang, K.; Radford-Smith, G.L.; Ahmad, T.; Lees, C.W.; Balschun, T.; Lee, J.; Roberts, R.; et al. Genome-wide meta-analysis increases to 71 the number of confirmed crohn's disease susceptibility loci. Nat. Genet 2010, 42,1118-1125. [CrossRef] [PubMed]
19. Huang, Y.; Yu, X.; Wang, L.; Zhou, S.; Sun, J.; Feng, N.; Nie, S.; Wu, J.; Gao, F.; Fei, B.; et al. Four genetic polymorphisms of lymphotoxin-a gene and cancer risk: A systematic review and meta-analysis. PLoS ONE 2013, 8, e82519. [CrossRef] [PubMed]
20. Song, Z.; Song, Y.; Yin, J.; Shen, Y.; Yao, C.; Sun, Z.; Jiang, J.; Zhu, D.; Zhang, Y.; Shen, Q.; et al. Genetic variation in the TNF gene is associated with susceptibility to severe sepsis, but not with mortality. PLoS ONE 2012, 7, e46113. [CrossRef] [PubMed]
21. Nieters, A.; Becker, N.; Linseisen, J. Polymorphisms in candidate obesity genes and their interaction with dietary intake of n-6 polyunsaturated fatty acids affect obesity risk in a sub-sample of the EPIC-heidelberg cohort. Eur. J. Nutr. 2002, 41, 210-221. [CrossRef] [PubMed]
22. Joffe, Y.T.; van der Merwe, L.; Carstens, M.; Collins, M.; Jennings, C.; Levitt, N.S.; Lambert, E.V.; Goedecke, J.H. Tumor necrosis factor-a gene -308 G/A polymorphism modulates the relationship between dietary fat intake, serum lipids, and obesity risk in black south african women. J. Nutr. 2010,140, 901-907. [CrossRef] [PubMed]
23. Meydani, S.N.; Lichtenstein, A.H.; Cornwall, S.; Meydani, M.; Goldin, B.R.; Rasmussen, H.; Dinarello, C.A.; Schaefer, E.J. Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived n-3 fatty acid enrichment. J. Clin. Investig. 1993, 92,105-113. [CrossRef] [PubMed]
24. Kroeger, K.M.; Carville, K.S.; Abraham, L.J. The -308 tumor necrosis factor-a promoter polymorphism effects transcription. Mol. Immunol. 1997, 34, 391-399. [CrossRef]
25. Wilson, A.G.; Symons, J.A.; McDowell, T.L.; McDevitt, H.O.; Duff, G.W. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 1997, 94, 3195-3199. [CrossRef] [PubMed]
26. Antonicelli, R.; Olivieri, F.; Cavallone, L.; Spazzafumo, L.; Bonafe, M.; Marchegiani, F.; Cardelli, M.; Galeazzi, R.; Giovagnetti, S.; Perna, G.P.; et al. Tumor necrosis factor-a gene -308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron. Artery Dis. 2005,16, 489-493. [CrossRef] [PubMed]
27. Browning, L.M.; Krebs, J.D.; Moore, C.S.; Mishra, G.D.; O'Connell, M.A.; Jebb, S.A. The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes. Metab. 2007, 9, 70-80. [CrossRef] [PubMed]
28. Ciubotaru, I.; Lee, Y.S.; Wander, R.C. Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J. Nutr. Biochem. 2003, 14, 513-521. [CrossRef]
29. Rasic-Milutinovic, Z.; Perunicic, G.; Pljesa, S.; Gluvic, Z.; Sobajic, S.; Djuric, I.; Ristic, D. Effects of n-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients. Ren. Fail. 2007, 29, 321-329. [CrossRef] [PubMed]
30. Poudel-Tandukar, K.; Sato, M.; Ejima, Y.; Nanri, A.; Matsushita, Y.; Imaizumi, K.; Mizoue, T. Relationship of serum fatty acid composition and desaturase activity to C-reactive protein in japanese men and women. Atherosclerosis 2012, 220, 520-524. [CrossRef] [PubMed]
31. Eating well with canada's food guide. Available online: http://www.hc-sc.gc.ca/fn-an/food-guide-aliment/index-eng.php (accessed on 3 February 2016).
32. Goulet, J.; Nadeau, G.; Lapointe, A.; Lamarche, B.; Lemieux, S. Validity and reproducibility of an interviewer-administered food frequency questionnaire for healthy french-canadian men and women. Nutr. J. 2004, 3,13. [CrossRef] [PubMed]
33. Callaway, C.W.; Chumlea, W.C.; Bouchard, C.; Himes, J.H.; Lohman, T.G.; Martin, A.D.; Mitchell, C.D.; Mueller, W.H.; Roche, A.F.; Seefeldt, V.D. The Airlie (VA) Consensus Conference; Human Kinetics Publishers: Champaign, IR, USA, 1988; pp. 39-80.
34. Pirro, M.; Bergeron, J.; Dagenais, G.R.; Bernard, P.M.; Cantin, B.; Despres, J.P.; Lamarche, B. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch. Intern. Med. 2001,161, 2474-2480. [CrossRef] [PubMed]
35. Shaikh, N.A.; Downar, E. Time course of changes in porcine myocardial phospholipid levels during ischemia. A reassessment of the lysolipid hypothesis. Circ. Res. 1981, 49, 316-325. [CrossRef] [PubMed]
36. Fozzard, H.A.; Haber, E.; Jennings, R.B.; Katz, A.M. The Heart and Cardiovascular System; Raven Press: New York, NY, USA, 1986.
37. Lepage, G.; Roy, C.C. Direct transesterification of all classes of lipids in a one-step reaction. J. Lip. Res. 1986, 27,114-120.
38. Livak, K.J. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet. Anal. Biomol. Eng. 1999, 14, 143-149. [CrossRef]
39. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2“aact method. Methods 2001, 25,402-408. [CrossRef] [PubMed]